| 词条 | Quinapril |
| 释义 |
| Watchedfields = changed | verifiedrevid = 464378463 | IUPAC_name = (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid | image = Quinapril structure.svg | width = 222 | tradename = Accupril, others | Drugs.com = {{drugs.com|monograph|quinapril-hydrochloride}} | MedlinePlus = a692026 | pregnancy_category = D | legal_status = Rx-only | routes_of_administration = By mouth | bioavailability = | protein_bound = 97% | metabolism = | elimination_half-life = 2 hours | IUPHAR_ligand = 6350 | CAS_number_Ref = {{cascite|correct|??}} | CAS_number = 85441-61-8 | ATC_prefix = C09 | ATC_suffix = AA06 | PubChem = 54892 | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | DrugBank = DB00881 | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ChemSpiderID = 49565 | UNII_Ref = {{fdacite|correct|FDA}} | UNII = RJ84Y44811 | KEGG_Ref = {{keggcite|correct|kegg}} | KEGG = D03752 | ChEBI_Ref = {{ebicite|correct|EBI}} | ChEBI = 8713 | ChEMBL_Ref = {{ebicite|correct|EBI}} | ChEMBL = 1592 | C=25 | H=30 | N=2 | O=5 | molecular_weight = 438.516 g/mol | smiles = O=C(OCC)[C@@H](N[C@H](C(=O)N2[C@H](C(=O)O)Cc1c(cccc1)C2)C)CCc3ccccc3 | StdInChI_Ref = {{stdinchicite|correct|chemspider}} | StdInChI = 1S/C25H30N2O5/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30)/t17-,21-,22-/m0/s1 | StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | StdInChIKey = JSDRRTOADPPCHY-HSQYWUDLSA-N | melting_point = 120 | melting_high = 130 }}Quinapril, sold under the brand name Accupril among others, is a medication used to treat high blood pressure, heart failure, and diabetic kidney disease.[1] It is a reasonable initial treatment for high blood pressure.[1] It is taken by mouth.[1] Common side effects include headaches, dizziness, feeling tired, and cough.[1] Serious side effects may include liver problems, low blood pressure, angioedema, kidney problems, and high blood potassium.[1] Use in pregnancy and breastfeeding is not recommended.[1] It is an ACE inhibitor and works by decreasing renin-angiotensin-aldosterone system activity.[2] Quinapril was patented in 1980 and came into medical use in 1989.[3] It is avaliable as a generic medication.[4] A month supply in the United Kingdom costs the NHS about 4 £ as of 2019.[4] In the United States the wholesale cost of this amount is about 3.50 USD.[5] In 2016 it was the 208th most prescribed medication in the United States with more than 2 million prescriptions.[6] Medical usesQuinapril is indicated for the treatment of high blood pressure (hypertension) and as adjunctive therapy in the management of heart failure. It may be used for the treatment of hypertension by itself or in combination with thiazide diuretics, and with diuretics and digoxin for heart failure. Contraindications
Side effectsSide effects of quinapril include dizziness, cough, vomiting, upset stomach, angioedema, and fatigue. Mechanism of actionQuinapril inhibits angiotensin converting enzyme, an enzyme which catalyses the formation of angiotensin II from its precursor, angiotensin I. Angiotensin II is a powerful vasoconstrictor and increases blood pressure through a variety of mechanisms. Due to reduced angiotensin production, plasma concentrations of aldosterone are also reduced, resulting in increased excretion of sodium in the urine and increased concentrations of potassium in the blood. References1. ^{{cite web |title=Quinapril Pregnancy and Breastfeeding Warnings |url=https://www.drugs.com/pregnancy/quinapril.html |website=Drugs.com |accessdate=3 March 2019 |language=en}} 2. ^1 2 3 4 5 {{cite web |title=Quinapril Hydrochloride Monograph for Professionals |url=https://www.drugs.com/monograph/quinapril-hydrochloride.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=3 March 2019 |language=en}} 3. ^{{cite book |last1=Fischer |first1=Jnos |last2=Ganellin |first2=C. Robin |title=Analogue-based Drug Discovery |date=2006 |publisher=John Wiley & Sons |isbn=9783527607495 |page=468 |url=https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA468 |language=en}} 4. ^1 {{cite book|title=British national formulary : BNF 76|date=2018|publisher=Pharmaceutical Press|isbn=9780857113382|pages=172|edition=76}} 5. ^{{cite web |title=NADAC as of 2019-02-27 |url=https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6 |website=Centers for Medicare and Medicaid Services |accessdate=3 March 2019 |language=en}} 6. ^{{cite web |title=The Top 300 of 2019 |url=https://clincalc.com/DrugStats/Top300Drugs.aspx |website=clincalc.com |accessdate=22 December 2018}} External links
9 : ACE inhibitors|Carboxamides|Butyrates|Enantiopure drugs|Pfizer products|Pfizer|Prodrugs|Tetrahydroisoquinolines|RTT |
| 随便看 |
|
开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。